Pancreatic Cancer Research

ResearcherVita-Salute San Raffaele UniversityActive in the last 2 years

Maria Pia Protti

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9079-2336; OpenAlex author ID A5036256432. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
26
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: none · 2023: 2 papers · 2024: 1 paper

Papers 10

  1. Anakinra-Loaded Sphingomyelin Nanosystems Modulate In Vitro IL-1-Dependent Pro-Tumor Inflammation in Pancreatic Cancer. Last author DOI 10.3390/ijms25158085↗
  2. Pro-tumor Tfh2 cells induce detrimental IgG4 production and PGE2-dependent IgE inhibition in pancreatic cancer. Last author DOI 10.1016/j.ebiom.2023.104819↗
  3. Immunomodulatory Effects of Endoscopic Ultrasound-Guided Thermal Ablation in Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers15143704↗
  4. B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/2162402x.2020.1794359↗
  5. Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2020.613582↗
  6. The IL-1/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreati… Last author DOI 10.1186/s40425-019-0521-4↗
  7. Basophil Recruitment into Tumor-Draining Lymph Nodes Correlates with Th2 Inflammation and Reduced Survival in Pancreatic Cancer Patients. Last author DOI 10.1158/0008-5472.can-15-1801-t↗
  8. Immune infiltrates as predictive markers of survival in pancreatic cancer patients. Co-author DOI 10.3389/fphys.2013.00210↗
  9. Cross-talk within the tumor microenvironment mediates Th2-type inflammation in pancreatic cancer. Co-author DOI 10.4161/onci.1.1.17939↗
  10. Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancrea… Last author DOI 10.1084/jem.20101876↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lucia B. De Monte · 9 shared papers, 2011–2024 · strength 0.92
  2. Massimo Falconi · 6 shared papers, 2016–2023 · strength 0.61
  3. Michele Reni · 5 shared papers, 2011–2023 · strength 0.46
  4. Claudio Doglioni · 4 shared papers, 2011–2023 · strength 0.31
  5. Gianpaolo Balzano · 3 shared papers, 2016–2023 · strength 0.28
  6. Marcelina Abal-Sanisidro · 1 shared paper, 2024 · strength 0.24
  7. María de la Fuente · 1 shared paper, 2024 · strength 0.24
  8. Stefano Crippa · 2 shared papers, 2020–2023 · strength 0.24
  9. Claudia Minici · 2 shared papers, 2020–2023 · strength 0.23
  10. Emanuel Della‐Torre · 2 shared papers, 2020–2023 · strength 0.23
  11. Paolo Giorgio Arcidiacono · 2 shared papers, 2020–2023 · strength 0.23
  12. Erica Dugnani · 2 shared papers, 2020 · strength 0.18
  13. Lorenzo Piemonti · 2 shared papers, 2020 · strength 0.18
  14. Giulio Belfiori · 1 shared paper, 2023 · strength 0.15
  15. Marco Schiavo Lena · 1 shared paper, 2023 · strength 0.15
  16. Sabrina Gloria Giulia Testoni · 1 shared paper, 2023 · strength 0.14
  17. Maria Chiara Petrone · 1 shared paper, 2023 · strength 0.14
  18. Francesco DE COBELLI · 1 shared paper, 2023 · strength 0.14
  19. Gabriele Capurso · 1 shared paper, 2023 · strength 0.14
  20. Emanuela Brunetto · 2 shared papers, 2016–2019 · strength 0.13
  21. Marina Macchini · 1 shared paper, 2020 · strength 0.09
  22. Angelo Corti · 1 shared paper, 2020 · strength 0.09
  23. Vikram Deshpande · 1 shared paper, 2020 · strength 0.09
  24. Sonja M. Wörmann · 1 shared paper, 2016 · strength 0.05
  25. Hana Algül · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.